Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Nutrition and Cancer|July 31, 1998
Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish menT J Hartman, J A Tangrea, P Pietinen, et al.
Cancer Causes & Control : CCC|March 5, 1998
Physical activity and prostate cancer in the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study (Finland)T J Hartman, D Albanes, M Rautalahti, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Establishment and evaluation of a serum cholesterol monitoring service in a community pharmacyT R Einarson, J L Bootman, W F McGhan, et al.
Cancer Research|December 5, 2000
Glutathione peroxidase codon 198 polymorphism variant increases lung cancer riskD Ratnasinghe, J A Tangrea, M R Andersen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 1998
The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention studyT J Hartman, D Albanes, P Pietinen, et al.
Therapeutic Drug Monitoring|January 1, 1985
Theophylline serum concentrations in ambulatory patients with chronic obstructive pulmonary diseaseJ W Bredon, J L Bootman, W N Jones, et al.
Anticancer Research|August 15, 2001
Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?D Ratnasinghe, P J Daschner, M R Anver, et al.
Cancer Causes & Control : CCC|March 1, 1996
Alcohol consumption and risk of colorectal cancer in a cohort of Finnish menS A Glynn, D Albanes, P Pietinen, et al.
Cancer Letters|February 17, 2001
Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in FinlandR R Misra, J A Tangrea, J Virtamo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1993
Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study GroupJ A Tangrea, E Adrianza, W E Helsel, et al.
Pageof 8